SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending due to a sharp sell-off triggered by a critical short-seller report from Muddy Waters, which alleged accounting irregularities and "Enron-esque" financial practices. The community is heavily focused on the company's aggressive rebuttal, CEO Anthony Noto's immediate purchase of shares, and widespread speculation that the report served as a liquidity grab for the short-sellers to exit their positions.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is undergoing a intense period of volatility as market participants debate whether the stock is a fundamental AI play or a parabolic bubble nearing a rug pull. While many in the community are focused on a potential super-cycle driven by memory chip shortages and institutional accumulation, others are aggressively shorting the stock, citing extreme valuation concerns and technical indicators that mirror previous market blow-offs.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. (SWMR) is seeing intense trading volume and volatility following a volatile IPO, with investors speculating on the potential of its combat-tested drone autonomy software. The community is actively debating the company's valuation against its early-stage financials while highlighting strong sector interest in defense technology and the potential for a massive short-term squeeze.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors aggressively position ahead of its quarterly earnings report, driven by optimistic sentiment surrounding HBM4 memory demand and its strategic role in Nvidias new AI platforms. The community remains deeply divided, with bulls highlighting a multi-year memory "super-cycle" and low forward valuation, while skeptical bears warn that the stock has become overextended and potentially vulnerable to a "sell the news" correction.

Tectonic is a decentralised non-custodial algorithmic-based money market protocol that allows users to participate as liquidity suppliers or borrowers. Suppliers provide liquidity to the market to earn a passive income, while borrowers are able to borrow liquidity in an over-collateralized fashion.

Tectonic

Tectonic is experiencing a surge in social sentiment as the community rallies around its potential for a major breakout, with many investors actively accumulating and holding in hopes of the token losing zeros. Discussions are largely driven by the expectation that the project will benefit from broader momentum within the Cronos ecosystem and the long-term potential of its vault-staking model.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing heightened community engagement as investors debate its regulatory status as a digital commodity, with many pointing to potential long-term network utility and institutional adoption. While some participants are aggressively accumulating through staking and DCA strategies, others are expressing frustration over stagnant price action and are closely monitoring key technical support levels to gauge the next move.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a significant surge in trading volume and upward price momentum as investors speculate on potential buyout interest and anticipate the upcoming earnings call. The community is actively discussing the stock's growth potential and best-in-class product profile, with many anticipating that institutional accumulation could drive the share price higher following recent technical breakouts.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing high volatility as traders react to persistent geopolitical tensions in the Strait of Hormuz and conflicting reports regarding the potential for an international tanker escort coalition. Community sentiment is deeply polarized, with many market participants debating whether the rally is a structural response to supply disruptions or a manipulated move driven by government intervention and treasury-led shorting.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is currently trending as investors debate management's ability to secure a 'top-tier' hyperscaler tenant for their Texas data center project, with sentiment split between optimism over key leadership hires and frustration regarding delayed timelines. The community is closely watching for a definitive contract announcement, as bulls point to the company's behind-the-meter energy strategy as a major catalyst for long-term growth.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is gaining significant momentum as investors digest a string of seven-figure contract awards and active, high-priority work on its Gen-3 satellite constellation. The community is buzzing over the firms strengthening role in global defense and AI intelligence, with many traders closely watching for further launch schedules and potential acquisition narratives to catalyze the next leg up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ArriVent BioPharma, Inc. $AVBP Shares Sold by Hidden Lake Asset Management LP

Hidden Lake Asset Management LP cut its stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP - Free Report) by 48.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...

ArriVent BioPharma's (AVBP) Buy Rating Reaffirmed at BTIG Research

BTIG Research reissued a "buy" rating and set a $42.00 target price on shares of ArriVent BioPharma in a research report on Thursday...

ArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Here's Why...

Wall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 70.4% in ArriVent BioPharma, Inc. (AVBP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?

Here is how ArriVent BioPharma, Inc. (AVBP) and Ocugen (OCGN) have performed compared to their sector so far this year.

ArriVent BioPharma's (AVBP) Outperform Rating Reaffirmed at Oppenheimer

Oppenheimer reiterated an "outperform" rating and set a $50.00 price objective (up from $44.00) on shares of ArriVent BioPharma in a research note on Friday...

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $33.00

Citigroup raised their price objective on ArriVent BioPharma from $31.00 to $33.00 and gave the stock a "buy" rating in a research note on Friday...

ArriVent BioPharma Sees Unusually High Options Volume (NASDAQ:AVBP)

ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) saw unusually large options trading activity on Friday. Stock investors acquired 1,832 call options on the stock. This is an increase of...

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $44.00

HC Wainwright boosted their target price on shares of ArriVent BioPharma from $42.00 to $44.00 and gave the stock a "buy" rating in a report on Friday...

ArriVent Biopharma, Inc. Full Year Loss Increases

(RTTNews) - ArriVent Biopharma, Inc. (AVBP) reported Loss for its full year of -$166.31 million...

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Current Price	$24.01
Prev Close	$24.31
Open	$24.26
Dividend Yield	0.00%
50-Day Moving Average	$22.64
Beta	0.94
Avg. Volume	473,781.21
PE Ratio	-5.45

52-Week High	$27.22
52-Week Low	$15.47
Market Capitalization	$1.07B
EPS (Annual)	-$4.32
Price to Book	3.36
Revenue Per Employee	$0.00

AVBP
ArriVent BioPharma Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AVBP News

AVBPArriVent BioPharma Inc.